| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 73OS0QIN3O |
| InChI Key | MBKDYNNUVRNNRF-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | CH6O6P2 |
| Molecular Weight | 176.0 |
| AlogP | -0.7 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 115.06 |
| Molecular species | ACID |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 9.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | 3 | - | |
|
Enzyme
Lyase
|
- | 1250000 | - | 1250000 | - | |
|
Enzyme
Phosphatase
|
- | - | - | 140000 | - | |
|
Enzyme
Protease
Metallo protease
Metallo protease MAM clan
Metallo protease M10A subfamily
|
- | 49000 | - | - | - | |
|
Enzyme
Transferase
|
- | - | - | 9000000 | 2.39-3.11 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -13.18-18.33 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Renal Insufficiency, Chronic | 3 | D051436 | ClinicalTrials |
| Osteogenesis Imperfecta | 3 | D010013 | ClinicalTrials |
| Osteoporosis, Postmenopausal | 2 | D015663 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 43945 |
| ChEMBL | CHEMBL180570 |
| DrugBank | DB14078 |
| EPA CompTox | DTXSID8045696 |
| FDA SRS | 73OS0QIN3O |
| PDB | MDN |
| PubChem | 16124 |
| SureChEMBL | SCHEMBL66716 |
| ZINC | ZINC000008015016 |